British industry leaders fear tariffs imposed by President Trump could disrupt the supply and even the price of drugs ...

Swiss drugmaker Novartis said on Thursday it plans to spend $23 billion to build and expand 10 facilities in the U.S., as it ...

Health Secretary Robert F. Kennedy Jr. spent a portion of his speech on Friday to FDA staff deriding their past decisions, at ...

The European Commission plans to adopt emergency measures next week to stop the spread of bird flu in two regions of Poland, ...

Wockhardt Chairman Habib Khorakiwala warns that potential US tariffs on pharmaceutical products would harm Americans. He ...

It’s unclear whether tariffs will influence more companies to make more drugs in the U.S. like President Donald Trump is hoping for, some experts said.

While the White House is waging a trade war on behalf of US manufacturing, the largest and most important part of the US economy, one that has a trade surplus, not a gap, is under threat.

The pair examine industry trends, company closures, developments in the cell and gene space—and the reductions in force ...

China announced on Friday it will raise tariffs on US goods from 84% to 125%, in the latest escalation of a trade war bet ...

Novartis expects the new capacity will allow it to produce all of its key medicines “end to end” in the U.S., as the Trump ...

US stocks turned higher on Friday to cap a chaotic week on Wall Street, as investors weighed the latest tariff-related ...